We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+2.04%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$23.3B
AUM Growth
-$265M
Cap. Flow
-$917M
Cap. Flow %
-3.93%
Top 10 Hldgs %
47.97%
Holding
197
New
23
Increased
32
Reduced
40
Closed
30

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$386M
2
AON icon
Aon
AON
+$368M
3
CTLT
CATALENT, INC.
CTLT
+$282M
4
CRM icon
Salesforce
CRM
+$266M
5
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$184M

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$924M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$262M
3
CSGP icon
CoStar Group
CSGP
+$251M
4
INSP icon
Inspire Medical Systems
INSP
+$135M
5
WAB icon
Wabtec
WAB
+$123M

Sector Composition

Rank Sector Weight
1 Healthcare 29.33%
2 Technology 12.47%
3 Financials 9.64%
4 Industrials 5.44%
5 Communication Services 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IONS icon
126
Ionis Pharmaceuticals
IONS
$9.93B
$229K ﹤0.01%
4,800
-729,200
-99% -$29.9M
HUM icon
127
Humana
HUM
$45.5B
$224K ﹤0.01%
600
-51,100
-99% -$17.3M
ACLX
128
DELISTED
Arcellx
ACLX
$221K ﹤0.01%
4,000
– –
CHE icon
129
Chemed
CHE
$7.07B
$217K ﹤0.01%
400
– –
SBRA icon
130
Sabra Healthcare REIT
SBRA
$5.21B
$216K ﹤0.01%
14,000
– –
DYN icon
131
Dyne Therapeutics
DYN
$4.87B
$212K ﹤0.01%
+6,000
New +$174K
IOVA icon
132
Iovance Biotherapeutics
IOVA
$3.76B
$209K ﹤0.01%
26,000
– –
SNDX icon
133
Syndax Pharmaceuticals
SNDX
$1.75B
$205K ﹤0.01%
10,000
– –
RNAM
134
DELISTED
Avidity Biosciences
RNAM
$204K ﹤0.01%
5,000
-601,061
-99% -$17.2M
HIMS icon
135
Hims & Hers Health
HIMS
$7.88B
$202K ﹤0.01%
10,000
-1,666,000
-99% -$27.7M
RCM
136
DELISTED
R1 RCM Inc. Common Stock
RCM
$201K ﹤0.01%
16,000
– –
CGC
137
Canopy Growth
CGC
$472M
$194K ﹤0.01%
+30,000
New +$258K
SEDA.WS
138
DELISTED
SDCL EDGE Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A ordinary share at an exercise price of $11.50
SEDA.WS
$191K ﹤0.01%
866,250
– –
PACB icon
139
Pacific Biosciences
PACB
$420M
$185K ﹤0.01%
135,000
-3,637,452
-96% -$7.35M
ALT icon
140
Altimmune
ALT
$605M
$184K ﹤0.01%
27,600
-442,400
-94% -$3.26M
GRFS
141
Grifois
GRFS
$5.44B
$177K ﹤0.01%
28,000
– –
OSCR icon
142
Oscar Health
OSCR
$9.89B
$174K ﹤0.01%
11,000
– –
ARDX icon
143
Ardelyx
ARDX
$1B
$170K ﹤0.01%
23,000
– –
FOLD
144
DELISTED
Amicus Therapeutics
FOLD
$159K ﹤0.01%
16,000
– –
CCCC icon
145
C4 Therapeutics
CCCC
$492M
$129K ﹤0.01%
28,000
– –
BYND icon
146
Beyond Meat
BYND
$254M
$127K ﹤0.01%
633
– –
IRWD icon
147
Ironwood Pharmaceuticals
IRWD
$709M
$84.8K ﹤0.01%
13,000
– –
IVCPW
148
DELISTED
Swiftmerge Acquisition Corp. Warrants
IVCPW
$79.2K ﹤0.01%
990,000
– –
CVIIW
149
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$70K ﹤0.01%
200,000
– –
SLDPW icon
150
Solid Power Inc Warrant
SLDPW
$6.93M
$64.6K ﹤0.01%
405,316
– –
4 5
6
7 8

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q2 2024 Portfolio in Review

As of Q2 2024, Thomas Steyer held 197 positions worth $23.3B, down 1.1% from $23.6B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Thomas Steyer withdrew a net $917M in Q2 2024, closing 30 positions and reducing 40 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $924M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Thomas Steyer opened a new position in Walt Disney worth $356M.

  • Thomas Steyer's largest Q2 2024 buy was Walt Disney: 3,582,168 shares worth $356M.
  • Thomas Steyer added most to Aon in Q2 2024, an estimated $368M increase.
  • Thomas Steyer's biggest Q2 2024 reduction was Alphabet (Google) Class C, cutting an estimated $262M.
  • Thomas Steyer fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $924M.
  • Thomas Steyer's ten largest holdings make up 48% of its $23.3B portfolio in Q2 2024.
  • Thomas Steyer opened 23 new positions and closed 30 in Q2 2024.
  • Thomas Steyer's portfolio value fell 1.1% quarter-over-quarter to $23.3B.

Based on Farallon Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.